Study conducted by Guettier et al. in South Indian population, showed that FABP2 genetic polymorphisms where neither associated with metabolic syndrome in patients with diabetes nor with dyslipidemia (P=0.682) (31). Here, FABP2 is linked to metabolic syndrome.